Classification: Pharmaceutical Intermediates
Cas NO.: 477600-75-2
Molecular Formula: C16H20N6O
Boiling Point: 585.845°C at 760 mmHg
Stability: null
Tofacitinib Citrate Intermediate. Tofacitinib (INN) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib citrate is marketed as Xeljanz and Jakvinus.